SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: Mr.Gogo who wrote (39447)9/28/2010 12:12:44 PM
From: Paul Senior  Read Replies (1) | Respond to of 78704
 
MON: Sold my shares earlier this year after seeing MON's earnings fall from Chinese generic competition to Monsanto's Roundup herbicide. I hadn't realized the extent to which MON's profits depend on these chemicals.

peacecountrysun.com

MON at current price is too expensive for me for a value play. (jmo)



To: Mr.Gogo who wrote (39447)9/28/2010 12:34:06 PM
From: Paul Senior  Read Replies (2) | Respond to of 78704
 
Fwiw, I did step up this morning for a few tracking shares of Bunge (BG) which is in the agriculture/food business.

BG's been profitable every year for the past decade, sells at a forward p/e at 11-12, and at .87 of book value. Book value growth has been erratic, but up over time. I look for the stock to sell at 1.2x book value or greater, where it's sold when the stock's been in more favor. P/sales now is somewhat below what its been over the past few years. Small dividend while waiting.

finance.yahoo.com